Analyze Diet
Tierarztliche Praxis. Ausgabe G, Grosstiere/Nutztiere2025; 53(2); 120-131; doi: 10.1055/a-2559-5769

[New drugs for horses and production animals in 2024].

Abstract: In 2024, there was no release of a novel pharmaceutical agent for horses and food-producing animals or an extension of existing active ingredients to other animal species on the German veterinary medicinal products market. Formic acid is now available for a new form of treatment, the short-term treatment of honeybees, and clenbuterol is available in a new dosage form, as an oral solution for horses. In the field of immunological veterinary medicinal products, three new vaccines were launched on the German veterinary medicinal products market. For the first time, a vaccine against in cattle, against also in cattle and against the H9 subtype of avian influenza in chicken are available. For pigs, a new vaccine with a known pathogen combination with type 2d of porcine circovirus, a new miscibility and needle-free application of products against respiratory pathogens and a new combination with serovar 11 in addition to serovars 2 and 9 of were approved. Furthermore, a new trivalent combination of three known vaccine antigens and a new miscibility of two products against diarrheal pathogens are available for pigs. A new recombinant combination product against infectious bursitis, infectious laryngotracheitis and Marek's disease has been approved for chicken. New administration methods were introduced to the market for a vaccine against bovine coronavirus (nasal) in cattle and porcine circovirus and (needleless) in pigs. Im Jahr 2024 kamen für Pferde und landwirtschaftliche Nutztiere weder neue Wirkstoffe noch bestehende Wirkstoffe für weitere Tierarten auf den deutschen Tierarzneimittelmarkt. Ameisensäure ist nun für eine neue Behandlungsform, der Kurzzeitbehandlung für Honigbienen, und Clenbuterol in einer neuen Darreichungsform, als orale Lösung für Pferde, verfügbar. Bei den immunologischen Tierarzneimitteln kamen 3 neue Impfstoffe auf den deutschen Tierarzneimittelmarkt. So steht erstmalig ein Impfstoff gegen bei Rindern, gegen ebenfalls bei Rindern sowie gegen den Subtyp H9 der Aviären Influenza bei Hühnern zur Verfügung. Für Schweine wurden ein neuer Impfstoff mit einer bekannten Erregerkombination mit dem Typ 2d des Porzinen Circovirus, eine neue Mischbarkeit und nadelfreie Anwendung von Produkten gegen Atemwegserreger und eine neue Kombination mit dem Serovar 11 neben den Serovaren 2 und 9 von zugelassen. Des Weiteren stehen für Schweine eine neue trivalente Kombination von 3 bekannten Impfantigenen sowie eine neue Mischbarkeit zweier Produkte gegen Durchfallerreger zur Verfügung. Ein neues rekombinantes Kombinationspräparat gegen die Infektiöse Bursitis, Infektiöse Laryngotracheitis und Marek‘sche Krankheit wurde für Hühner zugelassen. Neue Applikationsarten wurden für einen Impfstoff gegen das Bovine Coronavirus (nasal) bei Rindern und das Porzine Circovirus sowie (nadellos) bei Schweinen in den Markt eingeführt.
Publication Date: 2025-04-15 PubMed ID: 40233775DOI: 10.1055/a-2559-5769Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • English Abstract
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research article discusses the absence of new pharmaceutical agents for horses and food-producing animals in 2024 in the German veterinary medicinal products market. However, new forms of treatment, dosage forms, and vaccines were introduced, including a vaccine against H9 subtype of avian influenza in chickens and needle-free applications of products against respiratory pathogens in pigs.

New Treatment Methods and Dosages

  • The study emphasizes on the availability of formic acid as a new treatment method for honeybees and a new dosage form of clenbuterol, an oral solution for horses. These represent an advancement in the administration methods that can potentially benefit long-term animal health and wellbeing.

New Vaccines

  • The paper details on the launch of three new vaccines in the German veterinary medicinal products market. These are the vaccines against a particular disease in cattle, H9 subtype of avian influenza in chickens. The vaccines signify an evolution in the preventive measures against the diseases that could improve the overall health and lifespan of these animals.
  • For pigs, a new formulation of a vaccine with a known pathogen combination was approved, which features a new miscibility and needle-free application against respiratory pathogens. Furthermore, a new combination with serovar 11 was approved in addition to serovars 2 and 9. These additions and changes offer more effective and humane ways to protect pigs against diseases.

New Combinations and Administration Methods

  • The research mentions the approval of a new trivalent combination of three known vaccine antigens and a new miscibility of two products against diarrheal pathogens for pigs. These combinations potentially provide an enhanced defense against the pathogens that are responsible for diahorreal diseases in pigs.
  • For chickens, a new recombinant combination product against infectious bursitis, infectious laryngotracheitis, and Marek’s disease was approved. This points to improved ways of preventing these viral diseases that are considered hazardous for poultry health.
  • In terms of administration methods, novel methods were introduced for a vaccine against bovine coronavirus (nasal) in cattle and porcine circovirus (needleless) in pigs. These developments further contribute to not only effective disease prevention but also to the comfort of animals during administration of the vaccines.

Cite This Article

APA
Kamutzki CJ, Emmerich IU. (2025). [New drugs for horses and production animals in 2024]. Tierarztl Prax Ausg G Grosstiere Nutztiere, 53(2), 120-131. https://doi.org/10.1055/a-2559-5769

Publication

ISSN: 2567-5834
NlmUniqueID: 9715779
Country: Germany
Language: ger
Volume: 53
Issue: 2
Pages: 120-131

Researcher Affiliations

Kamutzki, Christin Jana
  • Institut für Pharmakologie, Pharmazie und Toxikologie, Veterinärmedizinische Fakultät der Universität Leipzig.
Emmerich, Ilka Ute
  • Institut für Pharmakologie, Pharmazie und Toxikologie, Veterinärmedizinische Fakultät der Universität Leipzig.

MeSH Terms

  • Animals
  • Horses
  • Veterinary Drugs / therapeutic use
  • Cattle
  • Horse Diseases / drug therapy
  • Germany

Conflict of Interest Statement

Frau Dr. med. vet. Christin Kamutzki erstellte das Manuskript im Rahmen ihrer externen Weiterbildung zur Fachtierärztin für Pharmakologie und Toxikologie bei Frau Dr. med. vet. Ilka Emmerich. Währenddessen war sie bei der Ceva Innovation Center GmbH beschäftigt.

Citations

This article has been cited 0 times.